Navigation Links
Study Shows Organon's Asenapine Demonstrates Efficacy and Tolerability in Treating Acute Schizophrenia
Date:11/14/2007

OSS, Netherlands, Nov. 14 /PRNewswire/ -- Asenapine -- a fast- dissolving, sublingual tablet being developed by Organon -- was shown to be effective and well-tolerated in patients with acute schizophrenia, according to a six-week study published in the current issue of the Journal of Clinical Psychiatry. These data were previously presented at the American Psychiatric Association's (APA) annual meeting and at the annual congress of the European College of Neuropsychopharmacology's (ECNP).

In the study, asenapine 5 mg twice daily was significantly more effective than placebo in improving both positive and negative symptoms associated with schizophrenia, based on the Positive and Negative Syndrome Scale (PANSS). This difference was seen starting at the second week of treatment. Positive symptoms include hallucinations and delusions; negative symptoms include lack of emotional expression.

"Currently available atypical antipsychotic drugs like risperidone are effective at reducing hallucinations and other positive symptoms associated with schizophrenia," said Steven G. Potkin, M.D., Department of Psychiatry and Human Behavior, University of California, Irvine. "Asenapine's effect on negative symptoms, as seen in our trial, is an interesting finding."

"These results further confirm asenapine's benefits in schizophrenia, and support our continued confidence in this agent as a potential treatment for this disorder," said Dr. Willem de Laat, executive vice president, medical affairs, Organon.

About the Study

In the study, 174 patients with schizophrenia were randomized to asenapine 5 mg twice daily, risperidone 3 mg twice daily, or placebo for six weeks. Asenapine was more effective than placebo in reducing total PANSS score as well as positive symptoms and negative symptoms when measured alone. Risperidone was more effective than placebo in reducing positive symptoms.

The majority of patients (83% asenapine, 79% placebo, 90% rispe
'/>"/>

SOURCE Organon
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... ... July 01, 2015 , ... Research published in the journal JAMA Ophthamology ... eyesight was just as accurate as those from standard paper-based charts and illuminated vision ... responsible for the development of the test, which does not depend on traditional familiarity ...
(Date:7/1/2015)... ... ... The Recovery Workforce Summit: 2015 PRA Annual Conference , presented by ... as a keynote on June 2nd in Philadelphia, PA. Stossel led a timely keynote ... power and reach to the essential message, while opening doors to wellness and recovery. ...
(Date:7/1/2015)... Lake City, UT (PRWEB) , ... July 01, ... ... to compare the different philosophies and approaches to case management, placement, sober companionship ... have different training and approaches to working with and transporting clients with anxiety, ...
(Date:7/1/2015)... Zurich, Switzerland (PRWEB) , ... July 01, 2015 ... ... enterprise collaboration across platforms and devices, today announced the opening of a new ... solutions, services, and support that enables collaboration across all lines of business for ...
(Date:7/1/2015)... ... 01, 2015 , ... Foot and Ankle Specialists of the Mid-Atlantic, LLC ... the annual Howard County Family Wellness Day event at Centennial Park on June 7, ... activities for children, free workout demonstrations, and more. Drs. Becker and Friske educated ...
Breaking Medicine News(10 mins):Health News:New Research Shows Reliability of Peek Eye Testing Mobile App 2Health News:New Research Shows Reliability of Peek Eye Testing Mobile App 3Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 2Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 3Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 4Health News:Scott Stossel, Editor of The Atlantic, Addressed Mental Health Professionals on Reducing Prejudice and Discrimination 5Health News:All Kinds of Therapy – Announces New Partnership Feature, Therapeutic Experts 2Health News:AvePoint Opens Office in Zurich to Meet Increasing Market Demand for Enterprise Collaboration Solutions in Switzerland 2Health News:AvePoint Opens Office in Zurich to Meet Increasing Market Demand for Enterprise Collaboration Solutions in Switzerland 3Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Promotes Healthy Living 2Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Promotes Healthy Living 3
... even a day after discharge, study finds , TUESDAY, April ... stents implanted to keep an artery open ignore their doctor,s ... that ignorance nearly doubles their risk for a heart attack ... 7,402 people who had the thin tubes put in after ...
... adding 30 pounds over 30 years, researchers say , TUESDAY, ... pounds over their lifetime steadily increase their risk for postmenopausal ... new study finds. , Earlier studies have linked excess weight ... but this is one of the few studies that traces ...
... and Elizabeth Epstein wanted to know whether cognitive ... delivered as couples therapy than when delivered as ... methods worked well, but women treated in couples ... those in individual therapy. Also, women suffering from ...
... ... Inc. (Stemedica) announced that the U.S. Food and Drug Administration (FDA) approved an Investigational ... proprietary allogeneic stem cells (adult human). , ... San Diego, California (PRWEB) April 20, 2010 -- ...
... ... without the stomach issues. The Company chose four test markets to evaluate adoption of ... ... ™ patches are newly released to the retail market. Many health conscious adults need ...
... study by the Columbia Center for Children,s Environmental Health ... prenatal exposure to pollutants can adversely affect children,s cognitive ... New York City (NYC) study. Researchers ... aromatic hydrocarbons (PAHs) in Krakow had a significant reduction ...
Cached Medicine News:Health News:Many Don't Take Blood Thinner After Getting Stents 2Health News:Many Don't Take Blood Thinner After Getting Stents 3Health News:Steady Weight Gain Boosts Late-Life Breast Cancer Risk 2Health News:Couples therapy can be the best choice for alcohol-dependent women with supportive spouses 2Health News:FDA Approves Stemedica IND for Ischemic Stroke Clinical Trial 2Health News:Peoria and Baltimore Serve as Test Markets for New Spot On Energy Product 2Health News:Children's cognitive ability can be affected by mother's exposure to urban air pollutants 2
(Date:7/1/2015)... 1, 2015  Unilife Corporation (NASDAQ: UNIS ... injectable drug delivery systems, announced today that its debt ... 30, 2015. This amendment removed a covenant that required ... receipts from customers during the six months ended June ... of the terms of the debt agreement as part ...
(Date:7/1/2015)... HEIGHTS, Utah , July 1, 2015 /PRNewswire/ ... ), a manufacturer and marketer of rehabilitation and ... completed its $4,025,000 private placement financing led by ... strategic private equity investor focused on the healthcare ... to promote organic growth and pursue potential strategic ...
(Date:7/1/2015)... 1, 2015  Imprimis Pharmaceuticals, Inc. (NASDAQ: ... development and commercialization of proprietary compounded drug formulations, ... Nasdaq stock market closing bell on Thursday, July ... of its Go Dropless™ campaign since its launch ... are performed annually in the U.S. and more ...
Breaking Medicine Technology:Unilife and OrbiMed Amend Debt Financing Agreement 2Unilife and OrbiMed Amend Debt Financing Agreement 3Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 3Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 2Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 3Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 4
... 2, 2010 Fiscal first quarter revenue from ... $641 million Fiscal first quarter adjusted income from ... $0.87 per share Fiscal first quarter GAAP income ... per share Rx segment revenue grew 47 percent ...
... IRVINE, Calif., Nov. 2, 2010 Endologix, Inc. (Nasdaq: ... for aortic disorders, announced today the first clinical implant ... City Hospital in Auckland, New Zealand.  The procedure was ... of Interventional Radiology) and Andrew, Hill, MD (Associate Professor ...
Cached Medicine Technology:Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 2Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 3Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 4Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 5Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 6Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 7Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 8Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 9Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 10Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 11Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 12Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 13Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 14Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 15Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 16Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 17Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 18Perrigo Reports Record Earnings and Raises Full Year Adjusted EPS Guidance 19Endologix Announces First Clinical Implant of Ventana™ Stent Graft 2Endologix Announces First Clinical Implant of Ventana™ Stent Graft 3Endologix Announces First Clinical Implant of Ventana™ Stent Graft 4
... Direct has been selling replacement ... 1996, and we are extremely ... guarantee. Check out our catalog ... our discount light bulbs specials. ...
... has been selling replacement bulbs ... and we are extremely proud ... Check out our catalog of ... discount light bulbs specials. ...
... Direct has been selling replacement ... 1996, and we are extremely ... guarantee. Check out our catalog ... our discount light bulbs specials. ...
... has been selling replacement bulbs ... and we are extremely proud ... Check out our catalog of ... discount light bulbs specials. ...
Medicine Products: